PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency

Blood

Volumn 121, Issue 5, 2013, Pages 791-800

  Ko, Nga Ling ^a   Taylor, John M ^a   Bellon, Marcia ^a   Bai, Xue Tao ^a   Shevtsov, Sergey P ^b   Dundr, Miroslav ^b   Nicot, Christophe ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COREPRESSOR PROTEIN; ENZYME ACTIVATOR; MESSENGER RNA; NUCLEAR RNA; PROTEASOME; PROTEASOME ACTIVATOR 28 GAMMA; PROTEIN P30; REX PROTEIN; TAX PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOGENICITY; LEUKEMIA CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA TRANSPORT; T CELL LEUKEMIA; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS LATENCY; VIRUS PARTICLE; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 84873528156     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-420414     Document Type: Article

References (32)

1. Saha A, Kaul R, Murakami M, Robertson ES. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther. 2010;10(10):961-978.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Nat Acad Sci U S A. 1980;77(12):7415-7419. (Pubitemid 11131140)
3. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Nat Acad Sci U S A. 1984;81(8):2534-2537.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Nat Acad Sci U S A. 1982; 79(6):2031-2035. (Pubitemid 12088563)
5. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270-280. (Pubitemid 46480972)
6. Mortreux F, Leclercq I, Gabet AS, et al. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst. 2001;93(5):367-377. (Pubitemid 32229381)
7. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol. 1995;69(5): 2863-2868.
8. Gillet NA, Malani N, Melamed A, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117(11):3113-3122.
9. Nicot C, Dundr M, Johnson JM, et al. HTLV-1- encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med. 2004;10(2): 197-201. (Pubitemid 38524892)
10. Choudhary G, Ratner L. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA. Virology. 2011;410(2):307-315.
11. Valeri VW, Hryniewicz A, Andresen V, et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood. 2010;116(19):3809-3817.
12. Kohler A, Hurt E. Exporting RNA from the nucleus to the cytoplasm. Nat Rev Mol Cell Biol. 2007; 8(10):761-773. (Pubitemid 47462133)
13. Cioce M, Boulon S, Matera AG, Lamond AI. UVinduced fragmentation of Cajal bodies. J Cell Biol. 2006;175(3):401-413.
14. Pancewicz J, Taylor JM, Datta A, et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Nat Acad Sci U S A. 2010;107(38):16619-16624.
15. Gao X, Li J, Pratt G, Wilk S, Rechsteiner M. Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma). Arch Biochem Biophys. 2004;425(2): 158-164. (Pubitemid 38542807)
16. Sinha-Datta U, Datta A, Ghorbel S, Dodon MD, Nicot C. Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J Biol Chem. 2007;282(19):14608-14615. (Pubitemid 47100421)
17. Knowlton JR, Johnston SC, Whitby FG, et al. Structure of the proteasome activator REGalpha (PA28alpha). Nature. 1997;390(6660):639-643. (Pubitemid 28016203)
18. Zhang Z, Clawson A, Realini C, et al. Identification of an activation region in the proteasome activator REGalpha. Proc Nat Acad Sci U S A. 1998;95(6):2807-2811. (Pubitemid 28135810)
19. Li J, Rechsteiner M. Molecular dissection of the 11S REG (PA28) proteasome activators. Biochimie. 2001;83(3-4):373-383. (Pubitemid 32293660)
20. Barton LF, Runnels HA, Schell TD, et al. Immune defects in 28-kDa proteasome activator gammadeficient mice. J Immunol. 2004;172(6):3948-3954. (Pubitemid 38337983)
21. Younis I, Khair L, Dundr M, et al. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol. 2004;78(20):11077-11083. (Pubitemid 39299648)
22. Nicot C, Astier-Gin T, Edouard E, et al. Establishment of HTLV-1-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res. 1993;30(3):317-334. (Pubitemid 23356284)
23. Kimata JT, Wong FH, Wang JJ, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994;204(2):656-664. (Pubitemid 24330871)
24. Derse D, Mikovits J, Polianova M, Felber BK, Ruscetti F. Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. J Virol. 1995;69(3):1907-1912.
25. Elovaara I, Koenig S, Brewah AY, et al. High human T cell lymphotropic virus type 1 (HTLV-1)- specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993;177(6): 1567-1573. (Pubitemid 23146123)
26. Martin D, Gutkind JS. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene. 2008;27 Suppl 2:S31-S42.
27. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol. 2000;18: 665-708. (Pubitemid 30365394)
28. Anupam R, Datta A, Kesic M, et al. Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival. J Biol Chem. 2011;286(9):7661-7668.
29. Baydoun HH, Pancewicz J, Nicot C. Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood. 2011;117(22):5897-5906.
30. Baydoun HH, Pancewicz J, Bai X, Nicot C. HTLV-1 p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol Cancer. 2010; 9:302.
31. Afonso PV, Mekaouche M, Mortreux F, et al. Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood. 2010;116(19):3802-3808.
32. Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2- mediated degradation. EMBO J. 2008;27(6):852-864. (Pubitemid 351417171)